HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Sillifant, K. Articles by Crabb, M. Search for Related Content PubMed Articles by Sillifant, K. Articles by Crabb, M.

Monitoring of patients on high dose antipsychotic medication

Unit of Child Mental Health, 12A Clarendon Road, Leeds LS2 9NN

Jacqueline Muir, Senior Registrar in Psychiatry

Northowram Hospital, Halifax

Stephen Read, Senior Lecturer in Psychiatry of Learning Disabilities

Crooked Acres, 1 Spen Lane, Leeds LS5 3EG

Mary Crabb, Pharmacist

High Royds Hospital, Menston, West Yorkshire LS29 6AQ

^* Correspondence

In the light of recently published Royal College of Psychiatrists' guidelines on the use of high dose antipsychotic medication, electrocardiographic and blood investigations were performed on 11 patients with learning disabilities receiving such treatment. All patients had normal electrocardiograms (ECGs). Four patients had asymptomatic low white cell counts and mild anaemia was detected in three individuals. Three patients were hyponatraemic; liver function tests were essentially normal. Issues around routine monitoring of such patients are discussed.